Navigation Links
ResMed Announces Conference Call And Webcast To Discuss Second Quarter 2014 Results
Date:12/18/2013

SAN DIEGO, Dec. 18, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, January 23, 2014, it will release its results for the second quarter and six months of fiscal year 2014, ended December 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. US Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q2 2014 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:9:30 p.m. 

London8:30 a.m. 

Sydney, Australia (January 24, 2014)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

US:

847-585-4405 Outside US:

+1 847-585-4405Conference Name:

Q2 2014 ResMed Inc. Results Conference Call Participant Passcode:

36303553The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

US:630- 652-3042Outside US:+1 630-652-3042Passcode:36303553ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.

Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's website at www.resmed.com.


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BMC to protect its rights in patent fight with ResMed
2. Apex reagiert energisch auf ResMed Patentklage
3. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
4. ResMed Inc. Announces Record Financial Results For The Quarter Ended September 30, 2013
5. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
6. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
7. Apex Fights Back Against ResMeds Patent Litigation
8. ResMed Takes New Action to Enforce Patents
9. ResMed Succeeds in Patent Fight Against APEX
10. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
11. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ORLANDO, Fla. , Feb. 10, 2016 /PRNewswire/ ... of technologies and products that help uncover the ... and Swift Biosciences Inc., a developer of innovative ... collaboration and co-marketing partnership aimed at enabling translational ... few as a couple hundred tumor and normal ...
(Date:2/10/2016)... Fla. , Feb. 9, 2016  Until recently, ... were surgery or liposuction. Thankfully, the FDA approved the ... them to death. Coolsculpting was originally approved in 2010 ... the thighs and now the chin. With this add-on ... Center can use a smaller applicator, the CoolMini, to ...
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Ongoing news of ... Life Care Association™ (ALCA) to conduct a survey that takes a closer look at ... today illustrates the prevalence and causes of TBI among the aging population, and identifies ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... time Emmy award winner and inspirational speaker Jan Fox will serve as keynote ... Speaking Boldly will provide participants with tools to more effectively communicate with their ...
Breaking Medicine News(10 mins):